Envista (NYSE:NVST) Hits New 12-Month Low – Should You Sell?

Envista Holdings Co. (NYSE:NVST)’s stock price reached a new 52-week low during trading on Friday . The company traded as low as $14.82 and last traded at $15.13, with a volume of 290644 shares traded. The stock had previously closed at $16.10.

Analyst Ratings Changes

NVST has been the subject of a number of analyst reports. UBS Group reduced their target price on shares of Envista from $23.00 to $21.00 and set a “neutral” rating for the company in a research note on Monday, March 10th. Jefferies Financial Group boosted their target price on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a report on Thursday, January 23rd. New Street Research set a $19.00 price target on shares of Envista in a research report on Thursday, March 6th. Morgan Stanley lowered their price objective on shares of Envista from $20.00 to $19.00 and set an “equal weight” rating on the stock in a research note on Thursday, March 6th. Finally, Piper Sandler raised their price target on shares of Envista from $17.00 to $18.00 and gave the stock a “neutral” rating in a research report on Monday, February 3rd. Two research analysts have rated the stock with a sell rating, ten have assigned a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus price target of $20.18.

Envista Trading Down 4.9 %

The business’s 50-day simple moving average is $19.30 and its 200-day simple moving average is $19.55. The company has a market capitalization of $2.64 billion, a price-to-earnings ratio of -2.35, a P/E/G ratio of 1.27 and a beta of 1.12. The company has a debt-to-equity ratio of 0.44, a quick ratio of 1.76 and a current ratio of 2.04.

Envista (NYSE:NVST) last announced its quarterly earnings results on Wednesday, February 5th. The company reported $0.24 EPS for the quarter, beating analysts’ consensus estimates of $0.23 by $0.01. Envista had a positive return on equity of 3.86% and a negative net margin of 44.56%. On average, research analysts expect that Envista Holdings Co. will post 1 earnings per share for the current fiscal year.

Institutional Trading of Envista

Several hedge funds have recently added to or reduced their stakes in NVST. Cerity Partners LLC grew its position in shares of Envista by 40.1% in the 3rd quarter. Cerity Partners LLC now owns 37,995 shares of the company’s stock valued at $751,000 after purchasing an additional 10,883 shares during the period. Glenmede Trust Co. NA bought a new position in Envista during the 3rd quarter worth about $217,000. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC raised its stake in shares of Envista by 0.8% in the 3rd quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 425,502 shares of the company’s stock valued at $8,408,000 after purchasing an additional 3,199 shares during the period. Janus Henderson Group PLC raised its stake in shares of Envista by 8.9% in the 3rd quarter. Janus Henderson Group PLC now owns 1,369,810 shares of the company’s stock valued at $27,067,000 after purchasing an additional 112,288 shares during the period. Finally, Point72 Asset Management L.P. bought a new stake in shares of Envista in the third quarter valued at about $37,559,000.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.